相关实验视频
Updated: May 23, 2025
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.2K
瑞典高级帕金森病的治疗方法:使用真实世界的数据进行成本效益分析
Dag Nyholm1, Simon Eggington2, Astrid Holm3
1Department of Medical Sciences, Neurology, Uppsala University, Uppsala, Sweden.
Neurology and therapy
|March 21, 2025
概括
深度大脑刺激 (DBS) 是瑞典对帕金森病的最具成本效益的治疗方法. 虽然DBS提供了显著的好处,但需要进一步的研究才能充分了解所有设备辅助疗法的长期结果.
科学领域:
- 卫生经济学 卫生经济学
- 神经学 神经学
- 医疗技术评估 医疗技术评估
背景情况:
- 瑞典帕金森病 (PD) 注册表提供了有关使用设备辅助疗法 (DAT) 的患者的成本和生活质量的宝贵现实数据.
- 这项研究旨在使用该注册表数据评估瑞典特定DAT的成本效益.
研究的目的:
- 确定瑞典针对帕金森病的特定设备辅助疗法的成本效益概况.
- 为了比较深度大脑刺激 (DBS),levodopa-carbidopa肠凝和连续皮下阿波莫尔芬输液与最佳医疗治疗.
主要方法:
- 一个状态过渡 (马尔科夫) 模型被开发来模拟帕金森病的进展超过20年.
- 来自瑞典PD注册表的数据被用来将生活设施的成本和质量分配给健康状态.
- 模拟了四个治疗组:最好的医疗疗法,DBS,莱沃多巴-卡比多巴肠凝和阿波莫芬输液.
主要成果:
- 发现深度大脑刺激 (DBS) 是最具成本效益的干预措施,主导了所有其他模拟疗法.
- 灵敏度分析确定了Hoehn和Yahr阶段之间的过渡概率是不确定性的关键驱动因素.
- 从付款人和社会角度来看,结果是一致的.
结论:
- 深度大脑刺激 (DBS) 是瑞典医疗保健资源在帕金森病管理中具有成本效益的使用方法.
- 与所有DAT相关的长期症状控制和生活质量仍然存在不确定性.
- 进一步的研究和数据收集是必要的,以验证模型预测和指导未来的调查.
相关概念视频
01:24Parkinson's Disease: Treatment
178
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
178
01:15Parkinson's Disease: Overview
415
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
415
01:28Drug Therapy
34
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
34